Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
-0,89%
1 083,04
-9,76
-0,89%
—1 092,801 093,681 094,851 081,97——
SIXC
Communications
SIXC
Communications
SIXC
-0,39%
602,38
-2,36
-0,39%
—604,74604,74605,10601,34——
SIXE
Energy
SIXE
Energy
SIXE
+2,31%
1 242,83
+28,03
+2,31%
—1 214,801 220,811 243,821 220,81——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,62%
1 713,82
-10,75
-0,62%
—1 724,571 727,021 732,301 707,43——
SIXM
Financials
SIXM
Financials
SIXM
+0,09%
639,99
+0,56
+0,09%
—639,43641,58644,53637,50——
SIXR
Staples
SIXR
Staples
SIXR
-0,20%
837,46
-1,69
-0,20%
—839,15836,90840,48832,89——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,65%
214,22
-1,40
-0,65%
—215,62215,62216,21213,48——
SIXT
Technology
SIXT
Technology
SIXT
+0,78%
3 204,38
+24,86
+0,78%
—3 179,523 191,503 205,093 177,75——
SIXU
Utilities
SIXU
Utilities
SIXU
-1,23%
925,38
-11,53
-1,23%
—936,91935,42937,17923,20——
SIXV
Health care
SIXV
Health care
SIXV
-0,69%
1 442,71
-10,06
-0,69%
—1 452,771 445,931 447,431 434,91——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,16%
2 361,34
-3,84
-0,16%
—2 365,182 353,642 368,102 347,80——
4528:TYO
Ono Pharmaceutical Co Ltd
2 306,00 JP¥
-0,28%
(-6,50) 1K
30-apr, 13:33:22 (GMT+9)  ·   JPY
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
4528 tikeri uchun statistika yaratilmoqda...
Ochish
2 298 JP¥
Yuqori
2 315 JP¥
Past
2 260 JP¥
Bozor kapitali
1,15 trln
Oʻrtacha hajm
1,78 mln
Hajmi
657,40 ming
Dividend
3,47%
Choraklik dividendlar
20 JP¥
Eks-dividend sanasi
29-sen, 2025
P/E koeffitsiyenti
17,37
52 haftalik eng yuqori
2 674 JP¥
52 haftalik eng past
1 474 JP¥
Aksiya boʻyicha daromad
133 JP¥
Muomaladagi aksiyalar
514,12 mln
Xodimlar soni
4 ming
Yangiliklar
Internetdagi manbalardan
Profil
Ono Pharmaceutical Co., Ltd. is one of the largest pharmaceutical companies in Japan. It is headquartered in Chuo-ku, Osaka, Japan, with its major plants in Higashinari-ku, Osaka, and Fujinomiya, Shizuoka., and its central research institute at Minase, Shimamoto-cho, Mishima District, Osaka. Ono Pharmaceutical's roots go back to 1717 when Ichibei Ono started his dealer business of pharmaceuticals in Osaka. His business expanded and changed its name a few times, and became Ono Pharmaceutical Industrial Co., Ltd. in 1948. Ono has been listed in Tokyo Stock Exchange since 1963. Its consolidated earnings in the half year ending in March 2018 were 16 billion Japanese yen. Nivolumab, the cancer drug based on the research of Prof. Dr. Tasuku Honjo of Kyoto University, who received the Nobel Prize later in 2018, is marketed by both Ono Pharmaceutical and Bristol-Myers Squibb. In 2024, Harvard University and Ono Pharmaceutical entered into a joint research and drug development agreement. Under it, promising projects to test therapeutic targets will be selected over 5 years under the guidance of Harvard's Office of Technology Development, and ONO will fund the work. Wikipedia
Ono Pharmaceutical Co Ltd haqida
CEOGyo Sagara | Gyo Sagara
Xodimlar soni4,29 ming
Asos solingan1717
Bosh ofislarOsaka, Osaka, Yaponiya
Sektor-
Veb-saytono-pharma.com
Oxirgi hisobot
1-fev, 2026
Moliya davri
Ch.3 2026
Normallashtirilgan EPS / Taxminiy
-/ -JPY
Daromad / Taxminan
139,90 mlrd/ (129,40 mlrd taxm.)JPY
Q3 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
QisqachaOxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – JPY
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – JPY
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
112,31 mlrd
127,54 mlrd
129,60 mlrd
139,90 mlrd
Sotilgan mahsulotning tannarxi
45,24 mlrd
37,01 mlrd
34,96 mlrd
36,68 mlrd
Daromad narxi
45,24 mlrd
37,01 mlrd
34,96 mlrd
36,68 mlrd
Tadqiqot va ishlanmalarga xarajatlar
46,30 mlrd
36,25 mlrd
34,77 mlrd
33,53 mlrd
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
31,86 mlrd
31,09 mlrd
30,08 mlrd
31,73 mlrd
Operatsion xarajatlar
82,93 mlrd
68,53 mlrd
64,56 mlrd
67,00 mlrd
Jami operatsion xarajatlar
128,16 mlrd
105,54 mlrd
99,53 mlrd
103,68 mlrd
Operatsion daromad
-15,85 mlrd
22,00 mlrd
30,07 mlrd
36,22 mlrd
Boshqa nooperatsion daromad
21,00 mln
-
-
-
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-12,71 mlrd
22,65 mlrd
29,52 mlrd
37,20 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-15,67 mlrd
22,65 mlrd
29,52 mlrd
37,20 mlrd
Daromad soligʻi boʻyicha xarajat
-6,34 mlrd
5,02 mlrd
7,17 mlrd
8,31 mlrd
Amaldagi soliq stavkasi
49,90%
22,16%
24,30%
22,35%
Boshqa operatsion xarajatlar
1,31 mlrd
1,19 mlrd
-291,00 mln
1,73 mlrd
Sof foyda
-6,54 mlrd
17,67 mlrd
22,42 mlrd
28,86 mlrd
Sof foyda marjasi
-5,83%
13,86%
17,30%
20,63%
Har bir aksiya foydasi
-
-
-
-
Foizlar va investitsiyalardan olingan daromadlar
1,90 mlrd
1,43 mlrd
677,00 mln
1,39 mlrd
Foizlarni toʻlash xarajatlari
-
-773,00 mln
-1,23 mlrd
-408,00 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
1,90 mlrd
655,00 mln
-549,00 mln
979,00 mln
Amortizatsiya ajratmalari
3,45 mlrd
-
-
-
EBITDA
-7,13 mlrd
31,23 mlrd
39,39 mlrd
45,82 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
7,98 mlrd
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish